PDE4B/7A-IN-2
5-HT1A/5-HT7 receptor antagonist (5-HT1A Ki = 8 nM, Kb = 0.04 nM; 5-HT7 Ki = 451 nM, Kb = 460 nM) with PDE4B/PDE7A inhibitory activity (PDE4B IC50 = 80.4 μM; PDE7A IC50 = 151.3 μM), its antidepressant like effect is stronger than that of escitalopram as a reference agent.
Product Specifications
CAS Number
2511632-55-4
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/pde4b-7a-in-2.html
Solubility
10 mM in DMSO
Smiles
COC1=C(C=CC=C1)N2CCN(CC2)CCCCC(NC3=CC=C(C=C3)C(C)C)=O
Molecular Formula
C25H35N3O2
Molecular Weight
409.56
References & Citations
[1]Jankowska A, et al. Novel anilide and benzylamide derivatives of arylpiperazinylalkanoic acids as 5-HT1A/5-HT7 receptor antagonists and phosphodiesterase 4/7 inhibitors with procognitive and antidepressant activity. Eur J Med Chem. 2020 Sep 1;201:112437.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
5-HT1 Receptor;5-HT7 Receptor; PDE4; PDE7
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
32274-05171 5x 30 µg
Human CHST10 AssayLite™ Antibody (PerCP Conjugate)
Sign In for Pricing
View Details 